News | December 17, 2024
Merck to acquire HUB Organoids to advance cell culture portfolio
Acquisition to advance company's next generation biology portfolio with internationally recognized pioneer in organoid development
Acquisition to advance company's next generation biology portfolio with internationally recognized pioneer in organoid development
The company will also share results in two additional posters for deuruxolitinib
Wacker Biotech will manufacture the active ingredients of MinervaX’s novel vaccine candidate
Globally, colorectal cancer impacts 1.9 million people each year, standing as a leading cause of cancer mortality
Ace Lab conducts 170 batches of testing per month and has capacity to do more than 250 batches per month
Berlinger brings a suite of proprietary and high-quality hardware and software solutions that broaden Sensitech's end-to-end cold chain monitoring product portfolio
The transaction aligns with Lupin's strategy to grow its global presence in Specialty areas
Additional data from APPRAISE ATP trial reinforce modular therapy approach
Late-breaker Phase 3 STRIDE-10 trial presented as an oral presentation at European Society of Clinical Microbiology and Infectious Diseases
First and only immunotherapy to demonstrate survival benefit in this setting in a global Phase III trial
Subscribe To Our Newsletter & Stay Updated
